Abstract:HIV-1 associated neurocognitive disorders (HAND) develop during progressive HIV-1 infection and affect up to 50% of infected individuals. Activated microglia and macrophages are critical cell populations that are involved in the pathogenesis of HAND, which is specifically related to the production and release of various soluble neurotoxic factors including glutamate. In the central nervous system (CNS), glutamate is typically derived from glutamine by mitochondrial enzyme glutaminase. Our previous study has shown that glutaminase is upregulated in HIV-1 infected monocyte-derived-macrophages (MDM) and microglia. However, how HIV-1 leads to glutaminase upregulation, or how glutaminase expression is regulated in general, remains unclear. In this study, using a dual-luciferase reporter assay system, we demonstrated that interferon (IFN) α specifically activated the glutaminase 1 (GLS1) promoter. Furthermore, IFN-α treatment increased signal transducer and activator of transcription 1 (STAT1) phosphorylation and glutaminase mRNA and protein levels. IFN-α stimulation of GLS1 promoter activity correlated to STAT1 phosphorylation and was reduced by fludarabine, a chemical that inhibits STAT1 phosphorylation. Interestingly, STAT1 was found to directly bind to the GLS1 promoter in MDM, an effect that was dependent on STAT1 phosphorylation and significantly enhanced by IFN-α treatment. More importantly, HIV-1 infection increased STAT1 phosphorylation and STAT1 binding to the GLS1 promoter, which was associated with increased glutamate levels. The clinical relevance of these findings was further corroborated with investigation of post-mortem brain tissues. The glutaminase C (GAC, one isoform of GLS1) mRNA levels in HIV associated-dementia (HAD) individuals correlate with STAT1 (p<0.01), IFN-α (p<0.05) and IFN-β (p<0.01). Together, these data indicate that both HIV-1 infection and IFN-α treatment increase glutaminase expression through STAT1 phosphorylation and by binding to the GLS1 promoter. Since glutaminase is a potential component of elevated glutamate production during the pathogenesis of HAND, our data will help to identify additional therapeutic targets for the treatment of HAND.

Glutaminase 1 Regulates the Release of Extracellular Vesicles During Neuroinflammation Through Key Metabolic Intermediate Alpha-Ketoglutarate

Glutaminase Regulates Extracellular Vesicles Release Through Key Metabolic Intermediate Α-Ketoglutarate in HIV-1-infected Macrophages

Glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity

Glutaminase in Microglia: A Novel Regulator of Neuroinflammation

TNF-α Promotes Extracellular Vesicle Release in Mouse Astrocytes Through Glutaminase

In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage.

TNF-α Promotes Mouse Astrocytes Microvesicles Release Through Raised Glutaminase

Glutaminase C Regulates Microglial Activation and Pro-inflammatory Exosome Release: Relevance to the Pathogenesis of Alzheimer’s Disease

IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.

Glutaminase Dysregulation in Hiv-1-Infected Human Microglia Mediates Neurotoxicity: Relevant to Hiv-1-Associated Neurocognitive Disorders

Glutaminase 1 Regulates Neuroinflammation After Cerebral Ischemia Through Enhancing Microglial Activation and Pro-Inflammatory Exosome Release

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase.

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia.

Stat1 Regulates Human Glutaminase 1 Promoter Activity Through Multiple Binding Sites In Hiv-1 Infected Macrophages

Interferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders

Mitochondrial Glutaminase Release Contributes to Glutamate-Mediated Neurotoxicity during Human Immunodeficiency Virus-1 Infection

Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages

Glutaminase 1 is essential for the differentiation, proliferation, and survival of human neural progenitor cells.

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages